Bone Marrow Transplantation - Table of Contents alert Volume 48 Issue 2

Special Issue: Treatment and Hematopoietic Stem Cell Transplantation in Aplastic Anemia Guest Editor: Mahmoud Aljurf TABLE OF CONTENTS Volume 48, Issue 2 (February 2013) In this issue Special Issue Editorial Special Issue Reviews Reviews Special Report Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Stem Cell Biology Special Issue and Web Focus The January special issue of Cell Research and the accompanying web focus on Stem Cell Biology delves into our current understanding and investigates recent advances in various aspects of stem cell biology, cell reprogramming, and their relevance to diseases. Access the Stem Cell Biology Special Issue today!   Special Issue Editorial Top Treatment and hematopoietic SCT in aplastic anemia J R Passweg and M Aljurf Bone Marrow Transplant 2013 48: 161; advance online publication, November 19, 2012; 10.1038/bmt.2012.229 Full Text | PDF Special Issue Reviews Top Diagnosis of acquired aplastic anemia A Rovó, A Tichelli and C Dufour on behalf of the SAA-WP EBMT Bone Marrow Transplant 2013 48: 162-167; advance online publication, November 19, 2012; 10.1038/bmt.2012.230 Abstract | Full Text Supportive care in severe and very severe aplastic anemia B Höchsmann, A Moicean, A Risitano, P Ljungman and H Schrezenmeier for the EBMT Working Party on Aplastic Anemia Bone Marrow Transplant 2013 48: 168-173; advance online publication, December 3, 2012; 10.1038/bmt.2012.220 Abstract | Full Text Front-line immunosuppressive treatment of acquired aplastic anemia C Dufour, J Svahn, A Bacigalupo and on behalf of the Severe Aplastic Anemia–Working Party of the EBMT Bone Marrow Transplant 2013 48: 174-177; advance online publication, November 19, 2012; 10.1038/bmt.2012.222 Abstract | Full Text Standard treatment of acquired SAA in adult patients 18–40 years old with an HLA-identical sibling donor M Aljurf, H Al-Zahrani, M T Van Lint and J R Passweg Bone Marrow Transplant 2013 48: 178-179; advance online publication, November 19, 2012; 10.1038/bmt.2012.223 Abstract | Full Text Treatment of aplastic anaemia in elderly patients aged >60 years A Tichelli and J C W Marsh Bone Marrow Transplant 2013 48: 180-182; advance online publication, November 26, 2012; 10.1038/bmt.2012.224 Abstract | Full Text Haploidentical transplantation in patients with acquired aplastic anemia F Ciceri, M T Lupo-Stanghellini and E T Korthof on behalf of the SAA-WP EBMT Bone Marrow Transplant 2013 48: 183-185; advance online publication, January 7, 2013; 10.1038/bmt.2012.231 Abstract | Full Text Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab) A M Risitano and H Schrezenmeier Bone Marrow Transplant 2013 48: 186-190; advance online publication, December 10, 2012; 10.1038/bmt.2012.245 Abstract | Full Text Management of acquired aplastic anemia in children E T Korthof, A N Békássy and A A Hussein on behalf of the SAA-WP of the EBMT Bone Marrow Transplant 2013 48: 191-195; advance online publication, January 7, 2013; 10.1038/bmt.2012.235 Abstract | Full Text Management of adult patients older than 40 years refractory to at least one immunosuppressive course: HLA-identical sibling HSCT using fludarabine-based conditioning S Maury and M Aljurf Bone Marrow Transplant 2013 48: 196-197; advance online publication, December 10, 2012; 10.1038/bmt.2012.251 Abstract | Full Text Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18–40 years without an HLA-identical sibling and failing immunosuppression A Bacigalupo and J C W Marsh Bone Marrow Transplant 2013 48: 198-200; advance online publication, November 26, 2012; 10.1038/bmt.2012.233 Abstract | Full Text Cord blood transplantation in aplastic anemia R Peffault de Latour, V Rocha and G Socié Bone Marrow Transplant 2013 48: 201-202; advance online publication, January 7, 2013; 10.1038/bmt.2012.252 Abstract | Full Text Reviews Top Chronic GVHD: Where are we? Where do we want to be? Will immunomodulatory drugs help? Y P L Linhares, S Pavletic and R P Gale Bone Marrow Transplant 2013 48: 203-209; advance online publication, May 14, 2012; 10.1038/bmt.2012.76 Abstract | Full Text Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision R N Lown and B E Shaw Bone Marrow Transplant 2013 48: 210-219; advance online publication, April 9, 2012; 10.1038/bmt.2012.54 Abstract | Full Text Special Report Top Allogeneic hematopoietic stem cell donation—standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT) J P Halter, S M van Walraven, N Worel, M Bengtsson, H Hägglund, G Nicoloso de Faveri, B E Shaw, A H Schmidt, M Fechter, A Madrigal, J Szer, M D Aljurf, D Weisdorf, M M Horowitz, H Greinix, D Niederwieser, A Gratwohl, Y Kodera and D Confer Bone Marrow Transplant 2013 48: 220-225; advance online publication, July 9, 2012; 10.1038/bmt.2012.119 Abstract | Full Text Original Articles Top HISTOCOMPATIBILITY AND DONOR SELECTION Alternative donor SCT for the treatment of MHC Class II deficiency T N Small, W Qasim, W Friedrich, R Chiesa, J J Bleesing, A Scurlock, P Veys and M Sparber-Sauer Bone Marrow Transplant 2013 48: 226-232; advance online publication, September 24, 2012; 10.1038/bmt.2012.140 Abstract | Full Text PBSC mobilization in newly diagnosed patients with POEMS syndrome: outcomes and prognostic factors J Li, W Zhang, M-H Duan, L Jiao, T-N Zhu, B Han, L Zhang, J Gan and D-B Zhou Bone Marrow Transplant 2013 48: 233-237; advance online publication, July 23, 2012; 10.1038/bmt.2012.138 Abstract | Full Text ALLOGRAFTING The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT S Giebel, M Labopin, M Mohty, G J Mufti, D Niederwieser, J J Cornelissen, J J W M Janssen, N Milpied, L Vindelov, E Petersen, R Arnold, A Bacigalupo, D Blaise, C Craddock, A Nagler, F Frassoni, M Sadus-Wojciechowska and V Rocha Bone Marrow Transplant 2013 48: 238-242; advance online publication, July 9, 2012; 10.1038/bmt.2012.131 Abstract | Full Text Cryopreservation of allogeneic PBSC from related and unrelated donors is associated with delayed platelet engraftment but has no impact on survival P Medd, S Nagra, D Hollyman, C Craddock and R Malladi Bone Marrow Transplant 2013 48: 243-248; advance online publication, June 25, 2012; 10.1038/bmt.2012.118 Abstract | Full Text AUTOGRAFTING Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin’s lymphoma R Crocchiolo, L Castagna, S Fürst, J El-Cheikh, C Faucher, C Oudin, A Granata, R Bouabdallah, D Coso, C Chabannon, M Balzarotti, A Santoro and D Blaise Bone Marrow Transplant 2013 48: 249-252; advance online publication, June 25, 2012; 10.1038/bmt.2012.116 Abstract | Full Text MICROBIAL ISSUES Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: a Eurocord and Société Française de Greffe de Moelle-Therapie Cellulaire collaborative study P-Y Dumas, A Ruggeri, M Robin, A Crotta, J Abraham, E Forcade, J-O Bay, M Michallet, Y Bertrand, G Socié, I Ionescu, E Gluckman, N Milpied and V Rocha Bone Marrow Transplant 2013 48: 253-256; advance online publication, July 9, 2012; 10.1038/bmt.2012.117 Abstract | Full Text Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis M Ogata, T Satou, Y Inoue, K Takano, T Ikebe, T Ando, J Ikewaki, K Kohno, A Nishida, M Saburi, Y Miyazaki, E Ohtsuka, Y Saburi, T Fukuda and J Kadota Bone Marrow Transplant 2013 48: 257-264; advance online publication, July 2, 2012; 10.1038/bmt.2012.121 Abstract | Full Text Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients A Molinos-Quintana, C Pérez-de Soto, M Gómez-Rosa, J A Pérez-Simón and J M Pérez-Hurtado Bone Marrow Transplant 2013 48: 265-268; advance online publication, September 24, 2012; 10.1038/bmt.2012.134 Abstract | Full Text POST-TRANSPLANT EVENTS Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients M Foglietta, S S Neelapu, L W Kwak, Y Jiang, D Nattamai, S-T Lee, D H Fowler, C Sportes, R E Gress, S M Steinberg, L M Vence, L Radvanyi, K C Dwyer, M H Qazilbash, R N K Bryant and M R Bishop Bone Marrow Transplant 2013 48: 269-277; advance online publication, July 9, 2012; 10.1038/bmt.2012.132 Abstract | Full Text A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant S K Khaled, J Palmer, T Stiller, D Senitzer, R Maegawa, R Rodriguez, P M Parker, A Nademanee, J-L Cai, D S Snyder, C Karanes, E Osorio, S H Thomas, S J Forman and R Nakamura Bone Marrow Transplant 2013 48: 278-283; advance online publication, September 24, 2012; 10.1038/bmt.2012.175 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Early-phase GVHD gene expression profile in target versus non-target tissues: kidney, a possible target? B Sadeghi, H Al-Chaqmaqchi, S Al-Hashmi, D Brodin, Z Hassan, M Abedi-Valugerdi, A Moshfegh and M Hassan Bone Marrow Transplant 2013 48: 284-293; advance online publication, July 23, 2012; 10.1038/bmt.2012.120 Abstract | Full Text PHARMACO-ECONOMICS Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large National Private Claims Database N S Majhail, L W Mau, E M Denzen and T J Arneson Bone Marrow Transplant 2013 48: 294-300; advance online publication, July 9, 2012; 10.1038/bmt.2012.133 Abstract | Full Text Letters to the Editor Top Suicide after hematopoietic SCT: the story of AG U Rozovski, R Arad, O Ben-Tal, T Shahar and E Naparstek Bone Marrow Transplant 2013 48: 301-302; advance online publication, July 9, 2012; 10.1038/bmt.2012.122 Full Text | PDF G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT I N Micallef, E D Jacobsen, P Shaughnessy, P J Gandhi, G Calandra, F van Rhee and J Uberti Bone Marrow Transplant 2013 48: 303-304; advance online publication, July 9, 2012; 10.1038/bmt.2012.125 Full Text | PDF Are there still reasons to believe that high-dose chemotherapy has a role in breast cancer management? L Castagna and M Martino Bone Marrow Transplant 2013 48: 305; advance online publication, July 2, 2012; 10.1038/bmt.2012.126 Full Text | PDF Response to: ‘Are there still reasons to believe that high-dose chemotherapy plays a role in breast cancer management?’ T Demirer Bone Marrow Transplant 2013 48: 306; advance online publication, July 2, 2012; 10.1038/bmt.2012.127 Full Text | PDF Omission of day-11 MTX, in combination with tacrolimus, is not associated with increased risk of acute graft-versus-host disease after allo-BMT A Honda, K Kakihana, J Aoki, T Kobayashi, N Doki, H Sakamaki and K Ohashi Bone Marrow Transplant 2013 48: 307-309; advance online publication, July 2, 2012; 10.1038/bmt.2012.128 Full Text | PDF Stem cell mobilization in heavily pretreated multiple myeloma patients with prior high dose melphalan and auto-SCT Y Khaled, A Al-Hazzouri, A Mizrachi, R Reynolds, V Reddy and M Solh Bone Marrow Transplant 2013 48: 310-311; advance online publication, July 9, 2012; 10.1038/bmt.2012.135 Full Text | PDF Successful syngeneic PBSC transplantation for a patient with refractory Evans syndrome M Mori, M Hiwatari, J Takita, K Ida and H Kawaguchi Bone Marrow Transplant 2013 48: 312-313; advance online publication, July 16, 2012; 10.1038/bmt.2012.136 Full Text | PDF Donor selection for patients undergoing allogeneic hematopoietic SCT: assessment of the priorities of Canadian hematopoietic SCT physicians J Tay, D Allan, A Tinmouth, D Coyle and P Hébert Bone Marrow Transplant 2013 48: 314-316; advance online publication, July 30, 2012; 10.1038/bmt.2012.137 Full Text | PDF Autologous cord blood transplantation in a child with stage 4 neuroblastoma K-H Wu, S-M Wang, H-P Wu, T Weng, C-T Peng and Y-H Chao Bone Marrow Transplant 2013 48: 317-318; advance online publication, July 30, 2012; 10.1038/bmt.2012.146 Full Text | PDF Improved outcomes with novel agents and auto-SCT for multiple myeloma in African-American patients S L Saraf, P Patel, H Ozer, D J Peace, J G Quigley, N Mahmud and D Rondelli Bone Marrow Transplant 2013 48: 319-320; advance online publication, August 6, 2012; 10.1038/bmt.2012.148 Full Text | PDF Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.